ADBE vs TMO: Which Is the Better Buy?
Side-by-side comparison of Adobe Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Adobe Inc. · Technology
$238.25
+13.5% upside to fair value
Med Conviction
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+31.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ADBE |
TMO |
| Current Price |
$238.25 |
$658.32 |
| Fair Value Estimate |
$270.38 |
$863.34 |
| Upside to Fair Value |
+13.5%
|
+31.1%
|
| Market Cap |
$94.7B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
9.5x
|
25.9x
|
| Price / Sales |
3.6x
|
5.3x
|
| Price / FCF |
8.6x
|
33.4x
|
| Revenue Growth YoY |
+12.9%
|
+10.5%
|
| Gross Margin |
89.1%
|
40.4%
|
| Operating Margin |
35.7%
|
17.7%
|
| Return on Equity |
62.9%
|
13.4%
|
| Dividend Yield |
0% |
0.28% |
| FCF Yield |
11.63%
|
3.0%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Adobe is a global software provider organized into Digital Media, Digital Experience, and Publishing and Advertising, with Creative Cloud as its subscription flagship and Document Cloud as its cloud-native document platform. The business quality is high on fundamentals: TTM gross margin of 89.1%, TTM operating margin of 35.7%, TTM net margin of 28.0%, ROE of 62.9%, and free cash flow of $27.69 pe…
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
ADBE |
TMO |
| Zone Low |
$202.78 |
$647.50 |
| Zone High |
$229.82 |
$733.84 |
| In Buy Zone? |
No
|
Yes
|